Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay

Elena Riester, Peter Findeisen, J. Kolja Hegel, Michael Kabesch, Andreas Ambrosch, Christopher M Rank, Florina Langen, Tina Laengin, Christoph Niederhauser
doi: https://doi.org/10.1101/2021.03.02.21252203

Article usage

Article usage: March 2021 to July 2025

AbstractFullPdf
Mar 2021599316253
Apr 2021358952429
May 2021284952547
Jun 2021252697330
Jul 2021205628241
Aug 2021258906307
Sep 2021231879218
Oct 2021209521181
Nov 202195225128
Dec 202110818673
Jan 20226819767
Feb 2022367116
Mar 2022283318
Apr 2022274720
May 2022293717
Jun 2022302274
Jul 2022264457
Aug 202225456
Sep 2022346213
Oct 2022314510
Nov 202222515
Dec 2022293116
Jan 202328323
Feb 202328329
Mar 202326345
Apr 20232368
May 2023121410
Jun 202316152
Jul 20231289
Aug 2023213111
Sep 202316128
Oct 202315219
Nov 2023414010
Dec 202314128
Jan 202413198
Feb 202418343
Mar 202418286
Apr 202412388
May 202411195
Jun 20241457
Jul 202418119
Aug 202422258
Sep 202422219
Oct 202416244
Nov 2024171711
Dec 202426148
Jan 202528257
Feb 2025244717
Mar 2025293916
Apr 2025262621
May 2025223314
Jun 2025442912
Jul 2025202710
Back to top
Posted March 02, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay
Elena Riester, Peter Findeisen, J. Kolja Hegel, Michael Kabesch, Andreas Ambrosch, Christopher M Rank, Florina Langen, Tina Laengin, Christoph Niederhauser
medRxiv 2021.03.02.21252203; doi: https://doi.org/10.1101/2021.03.02.21252203
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area